You are here: Home » PTI Stories » National » News
Business Standard

Marksans Pharma gets EIR from USFDA for its Goa facility

Press Trust of India  |  New Delhi 

Drug firm today said it has received Establishment Inspection Report (EIR) from the US health regulator for its facility.

The company has received EIR from the United States Food and Drug Administration (USFDA) after inspection of its facility from April 3-7, 2017, said in a filing.

As per the USFDA, after the completion of an inspection of a facility, an EIR is issued to a company detailing inspectional findings.

of were today trading 2.30 per cent higher at Rs 48.85 per scrip in the afternoon trade on

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, October 09 2017. 15:48 IST